Aurora cannabis announces fiscal 2022 second quarter results

Global cannabis net revenue of $60.6 million adjusted ebitda improved by 22% to a loss of $9.0 million versus q1 2022 company reaffirms goal of adjusted ebitda profitability by h1/2023 transformation plan ahead of schedule; company now expects to realize upper end of $60 to $80 million range in total cost savings by h1/2023; ~$60 million annualized savings implemented to date company remains #1 canadian lp in global medical cannabis; international cannabis revenue increased 24% from q1 2022 nasdaq | tsx: acb edmonton, ab, feb. 10, 2022 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), the canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the second quarter fiscal 2022 ended december 31, 2021. "during the second quarter, we improved our adjusted ebitda by $2.5 million over q1, moving us closer to our profitability goal.
ACB Ratings Summary
ACB Quant Ranking